Goldman Sachs analysts raised their price target for shares of Intuitive Surgical (NSDQ:ISRG) after a strong third-quarter showing from the robotic surgery firm.
The researchers boosted their target from $362 to $412 and maintained their “neutral” rating in a note to investors.